Glucocorticoid resistant syndromes - Molecular basis and clinical presentations

Journal of Neuroendocrinology

Volumn 8, Issue 6, 1996, Pages 405-415

  Brönnegård, Mikael ^a   Stierna, Pontus ^a   Marcus, Claude ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetics; Glucocorticoid receptor; Glucocorticoid resistance; Mutagenesis; Mutations; Polymorphism

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

CELL DIFFERENTIATION; CLINICAL FEATURE; CUSHING SYNDROME; DIMERIZATION; DNA BINDING; GENE EXPRESSION REGULATION; GENE MUTATION; GENE STRUCTURE; GENETIC SUSCEPTIBILITY; HORMONAL REGULATION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; RNA SPLICING; RNA TRANSLATION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0029739959     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04781.x     Document Type: Review

References (105)

1. Munck A, Guyre PM. Glucocorticoid physiology, pharmacology and stress. In:Chrousos GP, Loriaux DL, and Lipsett MB, eds. Steroid Hormone Resistance: Mechanism and Clinical Aspects. Advances in Experimental Medicine and Biology. New York: Plenum Press, 1986; Vol. 196, 81-96.
2. Fuller PJ. The steroid receptor superfamily: mechanisms of diversity. FASEB J 1991;5: 3092-3099.
3. Laudet V, Hänni C, Coll J, Catzeflis F, Stehelin, D. Evolution of the nuclear receptor superfamily. EMBO J 1992;11: 1003-1015.
4. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers and heteromers. Endocrine Rev 1994;15: 391-407.
5. Carlstedt-Duke J, Wright A, Göttlicher M, Okret, S, Gustafsson J-Å. Molecular mechanisms of hormone action: regulation of target cell function by the steroid hormone receptor superfamily. In:Felig P, Baxter, JD, Frohman LA, eds, Endocrinology and Metabolism. New York: McGraw-Hill, Inc. Health Professions Division, 1995: 169-199.
6. Sanchez ER. Heat shock induces translocation to the nucleus of unliganded glucocorticoid receptor. J Biol Chem 1992;267: 17-20.
7. Gehring U, Mugele K, Ulrich J. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol Cell Endocrinol 1984;36: 107-112.
8. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto, KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987;1: 68-76.
9. Burnstein KL, Bellingham DL, Jewell CM, Powell-Oliver FE, Cidlowski JA. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991;56: 52-58.
10. Oakley RH, Cidlowski JA. Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Critical Rev Eukaryotic Gene Expr 1993;3(2): 63-88.
11. Silvia CM, Powell-Oliver FE, Jewell CM, Sar, M, Allgod VE, Cidlowski JA. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994;59: 436-442.
12. Eisen LP, Elsasser MS, Harmon JM. Positive regulation of the glucocorticoid receptor in human T-cells sensitive to the cytolytic effects of glucocorticoids. J Biol Chem 1988;263: 12044-12048.
13. Denton RR, Eisen LP, Elsasser MS, Harmon, JM. Differential autoregulation of glucocorticoid receptor expression in human T-and B-cell lines. Endocrinology 1993;133: 248-256.
14. Burnstein KL, Cidlowski JA. The down side of glucocorticoid receptor regulation. Mol Cell Endocrinol 1991;83: C1-C8.
15. Hollenberg SM, Weinberger C, Ong ES et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318: 635-641.
16. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metabol 1993;76: 17-23.
17. Smith EP, Boyd J, Frank, GR. Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 1994;331: 1056-1061.
18. Chrousos P, Detera-Wadleigh SD. Syndromes of glucocorticoid resistance. Ann Intern Med 1993;119: 1113-1124.
19. Komesaroff PA, Verity K, Fuller PJ. Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor. J Clin Endocrinol Metabol 1994;79: 27-31.
20. McLeod JF, Haddad JG. Syndromes of vitamin D resistance. In:Cohen MP, Foa PP. eds. Endocrinology and Metabolism: Progress in Research and Clinical Practice. New York: Springer-Verlag, p 120-146.
21. Jameson JL. Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone. Thyroid 1994;4: 485-492.
22. Nobukuni Y, Smith CL, Hager GL, Detera-Wadleigh, SD. Characterization of the human glucocorticoid receptor promoter. Biochemistry 1995;34: 8207-8214.
23. Bamberger CM, Bamberger AM, DeCastro M, Chrousos, GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid actions in humans. J Clin Invest 1995;95: 2435-2441.
24. Keaveney M, Parker MG, Gannon F. Identification of a functional role for the 3′ region of the human oestrogen receptor gene. J Molec Endocrinol 1993;10: 143-152.
25. Strähle U, Schmidt A, Kelsey G, Stewart AF, Cole, TJ, Schmid W, Schutz G. At least three promoters direct expression of the mouse glucocorticoid receptor gene. Proc Natl Acad Sci USA 1992;89: 6731-6735.
26. Denton RD, Hillman AG, Harmon JM. Unpublished results cited in reference 13.
27. Cooper DN. Human gene mutations affecting RNA processing and translation. Annals Medicine 1993;25: 11-17.
28. Atwater JA, Wisdom R, Verma IM. Regulated mRNA stability. Annual Review Genetics 1990;24: 519-541.
29. Salehi-Ashitiani K, Goldberg E. Posttranscriptional regulation of primate Ldhc mRNA by its AUUUA-like elements. Molecul Endocrinol 1995;9: 1782-1790.
30. Encio IJ, Detero-Wadleigh SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem 1991;266: 7182-7188.
31. Brönnegård M, Carlstedt-Duke J. The genetic basis of glucocorticoid resistance. Trends Endocrinol Metabol 1995;6: 160-164.
32. Hard T, Kellenbach E, Boelens R et al. Solution structure of the glucocorticoid receptor DNA-binding domain. Science 1990;249: 157-160.
33. Lamberts SWJ, Huizenga NTM, deLange P, deJong, FH, Koper JW. Clinical and experimental aspects of glucocorticoid resistance. Abstract presented at the XVII meeting of I.S.G.S.H, Berlin; 1995;25-28, Nov. 13.
34. Moalli PA, Rosen ST. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies. Leuk Lymph 1994;15: 363-374.
35. LaSpada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352: 77-79.
36. Riggins GJ, Lokey LK, Chastain JL, Leiner HA, Sherman SL, Wilkinson KD, Warren ST. Human genes containing polymorphic trinucleotide repeats. Nature Gen 1992;2: 186-191.
37. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz, KB. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone responsive elements and are dominantly inhibited by A-receptors. Molec Endocrinol 1993;7: 1256-1265.
38. Pratt WB. Transformation of glucocorticoid and progesterone receptors to the DNA binding state. J Cell Biochem 1987;35: 51-68.
39. Casdepond FC, Schweizer-Goyer G, Segard-Maurel IJ, Hollenberg SM, Giguere V, Evans RM, Baulieu EE. Heat-shock protein as a critical factor in maintaining glucocorticoid receptor in a nonfunctional state. J Biol Chem 1991;266: 5834-5841.
40. Brönnegård M, Werner S, Gustafsson J-Å. Regulation of glucocorticoid receptor expression in cultured fibroblasts from a patient with familial glucocorticoid resistance. J Ster Biochem Mole Biol 1991;39: 693-701.
41. Pfahl M. Nuclear receptor/AP-1 interaction. Endocrine Rev 1993;14: 651-658.
42. Harrison RJ, McNeil GP, Dobner PR. Synergistic activation of neurotensin/neuromedin N gene expression by c-jun and glucocorticoids; novel effects of fos family proteins. Molec Endocrinol 1995;9: 981-993.
43. Woolcock AJ, Barnes PJ. Supplement; asthma: the important question - part 2. Am Rev Respir Dis 1992;146: 1349-1366.
44. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee, TH, Barnes PJ. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995;154: 3500-3505.
45. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. Functional anatgonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 1990;62: 1217-1226.
46. Lucibello, FC, Slater EP, Jooss KU, Beato M, Muller R. Mutual transrepression of fos and the glucocorticoid receptor: involvement of a functional domain in fos which is absent in fosB. EMBO J 1990;9: 2827-2834.
47. Bodwell JE, Orti E, Hu LM, Coull JM, Pappin, DJ, Munck A. Phosphorylation of glucocorticoid receptors. J Cell Biochem 1992;16C: 2.
48. Orti E, Mendel DB, Munck A. Phosphorylation of the glucocorticoid receptor-associated and free forms of the 90-kDa heat shock protein before and after receptor activation. J Biol Chem 1989;264: 231-237.
49. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 1991;254: 1636-1639.
50. Sheppard KE, Roberts JL, Blum M. Differential regulaion of typell corticosteroid receptor messenger ribonucleic acid expression in the rat anterior pituitary and hippocampus. Endocrinology 1990;127: 431-439.
51. Palmer LA, Hukku B, Harmon JM. Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens. Cancer Res 1992;52: 6612-6618.
52. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JS, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Am Rev Respir Dis 1991;144: 1016-1025.
53. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH, Rowe D, Malchoff CD. Primary Cortisol resistance presenting as isosexual precocity. J Clin Endocrinol Metabol 1990;70: 503-507.
54. Malchoff CD, Malchoff DM. Glucocorticoid resistance in humans. Trends Endocrinol Metabol 1995;6: 89-95.
55. DeKloet ER. Brain corticosteroid receptor balance and homeostatic control. Frontier Neuroendocrinology 1991;12: 95-164.
56. Tordjman K, Jaffe A, Grazas N, Apter C, Stern, N. The role of the low dose (1μg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metabol 1995;80: 1301-1305.
57. Broide J, Soferman R, Kivity S, Golander A, Dickstein, G. Spirer Z, Weisman Y. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metabol 1995;80: 1243-1246.
58. Linkowski P, Van Onderbergen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E. Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol 1993;264 (Endocrinol Metabol 27): E173-E181.
59. Lane, SJ, Lee TH. Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid resistant bronchial asthma. Am Rev Respir Dis 1991;143: 1020-1024.
60. Munkholm P, Langholz E, Davidsen M, Binder V. Frequence of glucocorticoid resistance and dependency in Chrohn's disease. Gut 1994;35: 360-362.
61. Barnes P, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. TIPS 1993;14: 436-441.
62. Cypcar D, Busse WW. Steroid-resistant asthma. J Allergy Clin Immunol 1993;92: 362-372.
63. Powers JH, Hillman AG, Tang DC, Harmon JM. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and resistant human leukemic cells. Cancer Res 1993;53: 4059-4065.
64. Chikanza IC, Petrou P, Chrousos GP, Kingsley, G, Panayi GC. Defective hypothalamic response to immune/inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35: 1281-1288.
65. Sher ER, Leung DVM, Surs W, Kam JC, Kamada, AK, Szefler SJ. Steroid resistant asthma. Cellular mechanism contribut- ing to inadequate response to glucocorticoid therapy. J Clin Invest 1994;93: 33-39.
66. Norbiato G, Bevilaqua M, Vago T, Baldi G, Chebat E, Bertora P. Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metabol 1992;74: 608-613.
67. DiBattista JA, Martel-Pelletier J, Antakly T, Tardif JM, Pelletier JP. Reduced expression of glucocorticoid receptor levels in human osteoarthritis chondrocytes. Role in the suppression of metalloprotease synthesis. J Clin Endocrinol Metabol 1993;76: 1128-1134.
68. Allan R, Hodgson HJF. Inflammatory bowel disease. In:Pounder RE, ed. Recent Advances in Gastroenterology. 1988; London: Churcill Livingstone, 7: 1-21.
69. Meyrier A, Simon P. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis. Adv Nephrol 1988;17: 127-135.
70. Karl M, Lamberts SW. Detera-Wadleigh S et al. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metabol 1993;76: 683-689.
71. Robertson NM, Bodine PVN, Hsu TC, Alnemri ES, Litwack G. Modulator inhibits nuclear translocation of the glucocorticoid receptor and inhibits glucocorticoid-induced apoptosis in the human leukemic cell line CEM C-7. Cancer Res 1995;95: 2435-2441.
72. Simons SS. Function/Activity of specific amino acids in glucocorticoid receptors. Vitamins and Hormones 1994;49: 49-130.
73. Karl M, Aria K, Stratikis CA et al. Molecular studies of the glucocorticoid receptor in patients with generalized glucocorticoid resistance and steroid resistant asthma. 1995; Abstr 77th Annual Meeting, Endoc Soc, Washington DC, 3-55.
74. Hurley DM, Accili D, Stratikis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J din Invest 1991;87: 680-686.
75. Malchoff C, Brufsky A, Reardon G, McDermott P, Javier E, Bergh CH, Rowe D, Malchoff C. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 1993;91: 1918-1924.
76. Chakraborti PK, Garabedian MJ, Yamamoto KR, Simons SS. Role of cystein-640, cysteine-656, and cysteine-661 in steroid binding to rat glucocorticoid receptors. J Biol Chem 1992;267: 11366-11373.
77. Chakraborti PK, Garabedian MJ, Yamamoto KR, Simons SS. Creation of super glucocorticoid receptors by point mutations in the steroid binding domain. J Biol Chem 1991;266: 22075-22078.
78. Garabedian MJ, Yamamoto KR. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol Biol Cell 1992;3: 1245-1257.
79. Ashraf J, Thompson EB. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as 2 distinct receptor phenotypes. Mol Endocrinol 1993;7: 631-642.
80. Sluyser M. Hormone resistance in cancer: the role of abnormal steroid receptors. Crit Rev Oncogen 1994;5: 539-554.
81. Strasser-Wozak EMC, Hattmannstorfer R, Hala M, Hartman BL, Fiegl SG, Kofler R. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res 1995;55: 348-353.
82. Powers JH, Hillman AG, Tang DC, Harmon JM. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Res 1993;53: 4059-4065.
83. Moalli PA, Pillay S, Krett NL, Rosen ST. Alternative spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Res 1993;53: 3877-3879.
84. Huet-Minkowski M, Gasson JC, Bourgeois S. Induction of glucocorticoid-resistant variants in a murine thymoma line by antitumor drugs. Cancer Res 1981;41: 4540-4546.
85. i glucocorticoid receptor transcripts lack sequences encoding the amino-terminal transcriptional modulatory domain. Mol Cell Biol 1990;10: 4574-4581.
86. Chi CW, Sykes D, Ip MM. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines. Mol Cell Endocrinol 1989;62: 167-174.
87. Ip MM, Shea WK, Sykes D, Young DA. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions. Cancer Res 1991;51: 2786-2796.
88. Weaver JU, Hitman GA, Kopelman PG. An association between a Bell restriction fragment lenght polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese woman. J Molecul Endocrinol 1992;9: 295-3300.
89. Tomita M, Brandon DD, Chrousos GP et al, Glucocorticoid receptors in Epstein-Barr virus transformed lymphocytes from patients with glucocorticoid resistance and a glucocorticoid-resistant New World Primate species. J Clin Endocr Metabol 1986;62: 1145-1154.
90. Keightley M-C, Fuller PJ. Cortisol resistance and the guinea pig glucocorticoid receptor. Steroids 1995;60: 87-92.
91. Keightley M-C, Fuller PJ. Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity. Molecul Endocrinol 1991;8: 431-439.
92. Brandon DD, Markwick AJ, Flores M. Dixon K, Albertson BD, Loriaux DL. Genetic variation of the glucocorticoid receptor from a steroid-resistant primate. J Molecul Endocrinol 1991;7: 89-96.
93. Taymans SE, DeVries AC, DeVries MB, Carter CS, Detera-Wadleigh SD, Chrousos GP. A new rodent model of glucocorticoid resistance: possible role of glucocorticoid receptor alterations. Presented at the 77th Ann Meeting, Endoc Soc, Washington DC, P2-503.
94. Pepin M-C, Pothier F, Barden N. Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene. Nature 1992;355: 725-728.
95. Bourgeois S, Groul D, Newby R, Rajah FM. Expression of an mdr gene is associated with a new form of resistance to dexamethasone induced apoptosis. Molecul Endocr 1993;7: 840-851.
96. Kiss C. Impaired capacity of multidrug resistance related cytotoxic drugs to inhibit colony formation of dexamethasone-resistant human leukemic cell lines. Cancer Invest 1993;11: 358-360.
97. Lamberts SWJ, Koper JW, DeJong FH. Long-term treatment with RU486 and glucocorticoid receptor resistance: Theoretical and therapeutical implications. Trends Endocrinol Metabol 1992;3: 199-204.
98. Gaitan D, DeBold CD, Turney MK, Zhou P, Orth, DN, Kovacs WJ. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Molecul Endocrinol 1995;9: 1193-1201.
99. Karl M, von Wiehert G, Kempter E et al. Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metabol, 1995;81: 127-129.
100. Molijn GJ, Spek JJ, van Uffelen JCJ, de Jong, FH. Brinkman AO, Bruining HA, Lamberts SWJ, Koper JW. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metabol 1995;80: 1799-1803.
101. Stewart PM, Corrie JET, Shackelton CHL, Edwards CRW. Syndrome of apparent mineralocorticoid excess. J Clin Invest 1988;82: 340-349.
102. Fujii H, Iida S, Gomi M, Tsaguwa M, Kitani T, Moriwaki K. Augmented induction by dexamethasone of metallothionein IIA messenger ribonucleic acid in fibroblasts from a patient with cortisol hyperreactive syndrome. J Clin Endocrinol Metabol 1993;76: 445-449.
103. Panarelli M, Holloway CD, Mulatero P, Fraser R, Kenyon CJ. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leukocytes: A index of glucocorticoid sensitivity. J Clin Endocrinol Metabol 1994;78: 872-877.
104. Iida S, Moriwaki K, Fujii H et al. Quantitative comparison of aromatase induction by dexamethasone in fibroblasts from a patient with familial cortisol resistance and a patient with cortisol hyperreactive syndrome. J Clin Endocrinol Metabol 1991;73: 192-196.
105. Refetoff S, Weiss RE, Usala S. The syndromes of resistance to thyroid hormone. Endocrine Rev 1993;14: 348-399.